跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 63 条关于
“GBA2”
全部
63
临床试验
30
药物
21
机构
1
资讯
11
去年
Azafaros Secures €130M Funding to Advance Nizubaglustat into Phase III for Rare Lysosomal Storage Disorders
去年
GenEditBio Secures Investment to Advance Genome Editing Technologies
3个月前
Bial Completes Phase 2b ACTIVATE Study of Potential First-in-Class GBA1 Parkinson's Treatment
7个月前
Bial's Phase 2b ACTIVATE Study Reaches 75% Completion Milestone for GBA1-Associated Parkinson's Disease Treatment
去年
CAP-003 Gene Therapy Shows Promise for Parkinson's Disease with GBA Mutations
去年
VQ-101 Shows Promise in Phase 1 Trial for GBA-Parkinson's Disease
11个月前
Bial's BIA 28-6156 Reaches Key Milestone in Phase 2 Trial for GBA-Associated Parkinson's Disease
3年前
BIAL R&D Doses First Patient in Phase 2 Trial of BIA 28-6156 for Parkinson's Disease with GBA1 Mutation
11个月前
Vanqua Bio's VQ-101 Achieves Over 70% GCase Activation in Phase 1b Trial for GBA-Parkinson's Disease
去年
BIAL's BIA 28-6156 Phase 2 Trial Reaches Milestone with First Patient Completion
第 1 页,共 2 页
上一页
下一页